The Development Status and Future Trends of China’s Vaccine Industry

DOI

10.2991/aebmr.k.220307.420How to use a DOI?

Keywords

Vaccine industry; China; COVID-19

Abstract

The outbreak of the COVID-19 has focused the attention of various countries on the vaccine industry. China’s vaccine industry started late, has a small scale and has been presented less in international conference journals, but in the wake of this COVID-19, China has drawn significant attention to the vaccine industry to make a representative role. This research examines the history of China’s vaccine industry, the sector’s current state, how it compares to other countries, and the industry chain analysis. The vaccine sector in China is modest, but it is developing quickly and has many opportunities for improvement. Although there is still a significant gap with developed countries, the number of vaccine batches issued and the figures of domestic manufacturers are getting better every year. Many companies are actively involved in overseas clinical trials, and the internationalisation process is accelerating. The industrial chain of China’s vaccine industry involves manufacturers, batch issuing units and distributors, and disease control and prevention centres. With many vaccines on the market, the demand for vaccine packaging materials will increase significantly; the number of vaccine-related enterprises registered is picking up, and the number of medical institutions is also growing. In addition to improving medical laws and regulations, China should also innovate technical routes to speed up vaccine development.

Copyright

© 2022 The Authors. Published by Atlantis Press International B.V.

Open Access

This is an open access article under the CC BY-NC license.

Download article (PDF)

TY  - CONF
AU  - Xiyu Wang
PY  - 2022
DA  - 2022/03/26
TI  - The Development Status and Future Trends of China’s Vaccine Industry
BT  - Proceedings of the 2022 7th International Conference on Financial Innovation and Economic Development (ICFIED 2022)
PB  - Atlantis Press
SP  - 2573
EP  - 2582
SN  - 2352-5428
UR  - https://doi.org/10.2991/aebmr.k.220307.420
DO  - 10.2991/aebmr.k.220307.420
ID  - Wang2022
ER  -